Taylor Ben R
SEC CIK 1712276 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | CFO | 1.07M | — | $157.7K | 26 | 2024-12-16 | 2026-09-15 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 17:52 | 2026-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.41 | -5,396 | 1.07M | -0.5% | -$18.4K | |
| 2026-08-18 17:44 | 2026-08-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.16 | -25.0K | 1.08M | -2% | -$79.1K | |
| 2026-06-17 17:07 | 2026-06-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.15 | -5,396 | 1.10M | -0.5% | -$17.0K | |
| 2026-05-19 17:54 | 2026-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.04 | -25.0K | 1.11M | -2% | -$76.1K | |
| 2026-04-08 16:58 | 2026-04-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.11 | -48.0K | 1.13M | -4% | -$149.4K | |
| 2026-03-18 | 2026-03-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | S - Sale | $3.39 | -7,956 | 1.18M | -0.7% | -$27.0K | |
| 2026-03-18 | 2026-03-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.42 | -7,075 | 1.19M | -0.6% | -$24.2K | |
| 2026-02-19 | 2026-02-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.49 | -11.9K | 1.21M | -1.0% | -$41.6K | |
| 2026-02-19 | 2026-02-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | S - Sale | $3.08 | -13.4K | 1.20M | -1% | -$41.4K | |
| M | 2026-02-10 | 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | A - Grant | $0.00 | +470.5K | 1.23M | +62% | $0 |
| 2026-02-10 | 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $3.98 | -11.4K | 1.22M | -0.9% | -$45.4K | |
| 2025-12-30 | 2025-12-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | S - Sale | $4.18 | -21.4K | 761.5K | -3% | -$89.4K | |
| 2025-12-17 | 2025-12-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.33 | -7,057 | 782.9K | -0.9% | -$30.6K | |
| 2025-11-26 | 2025-11-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.03 | -2,271 | 790.0K | -0.3% | -$9,152 | |
| 2025-11-19 | 2025-11-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.14 | -11.9K | 792.3K | -1% | -$49.3K | |
| 2025-09-17 | 2025-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.83 | -7,057 | 804.2K | -0.9% | -$34.1K | |
| 2025-08-19 | 2025-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $5.64 | -11.9K | 811.2K | -1% | -$67.2K | |
| 2025-06-18 | 2025-06-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.92 | -7,057 | 823.1K | -0.9% | -$34.7K | |
| 2025-05-19 | 2025-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $4.25 | -11.9K | 830.2K | -1% | -$50.6K | |
| 2025-04-03 | 2025-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $5.10 | -26.6K | 842.1K | -3% | -$135.5K | |
| 2025-03-19 | 2025-03-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $6.84 | -7,057 | 868.7K | -0.8% | -$48.3K | |
| 2025-02-20 | 2025-02-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $10.64 | -10.9K | 875.7K | -1% | -$115.8K | |
| D | 2025-02-05 | 2025-02-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $7.25 | -6,544 | 886.6K | -0.7% | -$47.4K |
| DM | 2025-02-05 | 2025-02-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | A - Grant | $0.00 | +48.9K | 879.2K | +6% | $0 |
| D | 2024-12-20 | 2024-12-19 | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | A - Grant | $0.00 | +370.3K | 844.2K | +78% | $0 |
| M | 2024-12-18 | 2024-12-16+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | CFO | F - Tax | $6.32 | -22.7K | 480.9K | -5% | -$143.7K |
Purchase Sale Sale after option exercise All abbreviations